• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖凝集素-1、-3 和-8 在诱导 T 细胞反应中的冗余和拮抗功能。

Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.

机构信息

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Consejo Nacional de Investigaciones Científicas y Técnicas, B1650WGA San Martín, Buenos Aires, Argentina.

出版信息

J Immunol. 2012 Apr 1;188(7):2991-9. doi: 10.4049/jimmunol.1102182. Epub 2012 Feb 22.

DOI:10.4049/jimmunol.1102182
PMID:22357632
Abstract

Galectins, a family of mammalian lectins, have emerged as key regulators of the immune response. We previously demonstrated that galectin (Gal)-8, from the tandem-repeat subgroup, exerts two well-defined effects on mouse naive peripheral CD4 T cells: Ag-specific costimulation and Ag-independent proliferation. These stimulatory signals on naive T cells have not been described for any other Gal. Therefore, we investigated whether Gal-1 and Gal-3, two prominent members of the Gal family, share the stimulatory effects exerted by Gal-8 on naive T cells. We found that Gal-1 costimulated Ag-specific T cell responses similarly to Gal-8, as evaluated in the DO11.10 TCR(OVA)-transgenic mouse model, by acting simultaneously on APCs and target CD4 T cells. In contrast, Gal-3 failed to costimulate Ag-specific T cell responses; moreover, it antagonized both Gal-1 and Gal-8 signals. We observed that both Gal-1 and Gal-3 were unable to induce Ag-independent proliferation; however, when two Gal-1 molecules were covalently fused, the resulting chimeric protein efficiently promoted proliferation. This finding indicates that Gal-1 might eventually induce proliferation and, moreover, stresses the requirement of a tandem-repeat structure. Remarkably, a single dose of recombinant Gal-1 or Gal-8 administered together with a suboptimal Ag dose to DO11.10 mice strengthened weak responses in vivo. Taken together, these findings argue for the participation of Gals in the initiation of the immune response and allow the postulation of these lectins as enhancers of borderline Ag responses, thus representing potential adjuvants for vaccine formulations.

摘要

半乳糖凝集素是哺乳动物凝集素家族的一员,已成为免疫反应的关键调节因子。我们之前证明,来自串联重复亚群的半乳糖凝集素 (Gal)-8 对小鼠幼稚外周 CD4 T 细胞具有两种明确的作用:抗原特异性共刺激和抗原非依赖性增殖。尚未描述任何其他 Gal 对半乳糖凝集素的这些刺激信号。因此,我们研究了 Gal 家族的两个重要成员 Gal-1 和 Gal-3 是否具有 Gal-8 对幼稚 T 细胞的刺激作用。我们发现 Gal-1 类似于 Gal-8 共同刺激抗原特异性 T 细胞反应,通过同时作用于 APC 和靶 CD4 T 细胞,在 DO11.10 TCR(OVA)-转基因小鼠模型中进行评估。相比之下,Gal-3 不能共刺激抗原特异性 T 细胞反应;此外,它拮抗 Gal-1 和 Gal-8 的信号。我们观察到 Gal-1 和 Gal-3 均不能诱导抗原非依赖性增殖;然而,当两个 Gal-1 分子共价融合时,所得嵌合蛋白有效地促进了增殖。这一发现表明 Gal-1 可能最终诱导增殖,而且强调了串联重复结构的要求。值得注意的是,向 DO11.10 小鼠给予重组 Gal-1 或 Gal-8 单一剂量,同时给予亚最佳抗原剂量,可在体内增强弱反应。综上所述,这些发现表明半乳糖凝集素参与了免疫反应的启动,并使这些凝集素被推测为边界抗原反应的增强剂,因此代表了疫苗制剂的潜在佐剂。

相似文献

1
Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.半乳糖凝集素-1、-3 和-8 在诱导 T 细胞反应中的冗余和拮抗功能。
J Immunol. 2012 Apr 1;188(7):2991-9. doi: 10.4049/jimmunol.1102182. Epub 2012 Feb 22.
2
Galectin-8 provides costimulatory and proliferative signals to T lymphocytes.半乳糖凝集素-8为T淋巴细胞提供共刺激和增殖信号。
J Leukoc Biol. 2009 Aug;86(2):371-80. doi: 10.1189/jlb.0908529. Epub 2009 Apr 28.
3
Galectin-8 tandem-repeat structure is essential for T-cell proliferation but not for co-stimulation.半乳糖凝集素-8 串联重复结构对于 T 细胞增殖是必需的,但对于共刺激不是必需的。
Biochem J. 2011 Feb 15;434(1):153-60. doi: 10.1042/BJ20101691.
4
Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.半乳糖凝集素-1调节TCR结合和信号转导以调控CD8爆发规模。
J Immunol. 2009 May 1;182(9):5283-95. doi: 10.4049/jimmunol.0803811.
5
Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.初始CD4+ T细胞的共刺激需求。细胞间黏附分子-1(ICAM-1)或B7-1可共刺激初始CD4 T细胞活化,但最佳反应需要两者同时存在。
J Immunol. 1995 Jul 1;155(1):45-57.
6
Characterization of a double-CRD-mutated Gal-8 recombinant protein that retains co-stimulatory activity on antigen-specific T-cell response.一种双CRD突变的Gal-8重组蛋白的特性研究,该蛋白在抗原特异性T细胞应答中保留共刺激活性。
Biochem J. 2016 Apr 1;473(7):887-98. doi: 10.1042/BJ20150409. Epub 2016 Jan 21.
7
Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.抗原特异性B细胞优先诱导CD4+T细胞产生白细胞介素-4。
J Immunol. 1997 May 1;158(9):4171-9.
8
Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.半乳糖凝集素-1特异性调节T细胞受体信号,以增强T细胞受体凋亡,但抑制白细胞介素-2的产生和增殖。
J Immunol. 1999 Jan 15;162(2):799-806.
9
Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.体外激活的卵清蛋白(OVA)特异性和非特异性CD4+CD25+调节性T细胞对OVA介导的T细胞反应表现出相当的抑制作用。
Cell Immunol. 2006 Jun;241(2):75-84. doi: 10.1016/j.cellimm.2006.08.003. Epub 2006 Sep 27.
10
Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.Ia 在抗原特异性 T 细胞活化中的两种作用。II. 迈向抗原识别的“ Velcro 模型” 。
J Immunol. 1988 Apr 15;140(8):2500-7.

引用本文的文献

1
The interaction of Galectin-8 C-terminal domain with cell surface glycoconjugates modulates membrane elasticity to stimulate antigen uptake and presentation to CD4 T cells.半乳糖凝集素-8 C末端结构域与细胞表面糖缀合物的相互作用调节膜弹性,以刺激抗原摄取并呈递给CD4 T细胞。
J Leukoc Biol. 2025 Feb 13;117(2). doi: 10.1093/jleuko/qiae214.
2
Identification and validation of a prognostic risk-scoring model for AML based on mG-associated gene clustering.基于与微小颗粒相关基因聚类的急性髓系白血病预后风险评分模型的识别与验证。
Front Oncol. 2024 Jan 11;13:1301236. doi: 10.3389/fonc.2023.1301236. eCollection 2023.
3
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.
Vdelta1 T 细胞比 Vdelta2 T 细胞更能抵抗半乳糖凝集素-3 的免疫抑制特性。
Front Immunol. 2024 Jan 8;14:1286097. doi: 10.3389/fimmu.2023.1286097. eCollection 2023.
4
Inhibition of galectins in cancer: Biological challenges for their clinical application.抑制癌症中的半乳糖凝集素:其临床应用的生物学挑战。
Front Immunol. 2023 Jan 10;13:1104625. doi: 10.3389/fimmu.2022.1104625. eCollection 2022.
5
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors.新型3-三唑基-1-硫代半乳糖苷作为半乳糖凝集素-1、-3和-8抑制剂的设计与合成
RSC Adv. 2022 Jun 30;12(29):18973-18984. doi: 10.1039/d2ra03163a. eCollection 2022 Jun 22.
6
Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.基于铁死亡相关簇的急性髓系白血病预后风险评分模型的鉴定与验证
Front Cell Dev Biol. 2022 Jan 21;9:800267. doi: 10.3389/fcell.2021.800267. eCollection 2021.
7
Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment.胶质瘤中的半乳糖凝集素:在癌症进展中的当前作用及改善治疗的未来方向
Cancers (Basel). 2021 Nov 4;13(21):5533. doi: 10.3390/cancers13215533.
8
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.解析肿瘤衍生的半乳糖凝集素如何导致抗癌免疫失败。
Cancers (Basel). 2021 Sep 9;13(18):4529. doi: 10.3390/cancers13184529.
9
Immunomodulatory effects of galectin-1 in patients with chronic lymphocytic leukemia.半乳糖凝集素-1对慢性淋巴细胞白血病患者的免疫调节作用
Cent Eur J Immunol. 2021;46(1):54-62. doi: 10.5114/ceji.2021.105246. Epub 2021 Apr 18.
10
Purification of Recombinant Galectins Expressed in Bacteria.重组细菌表达半乳糖凝集素的纯化。
STAR Protoc. 2020 Dec 9;1(3):100204. doi: 10.1016/j.xpro.2020.100204. eCollection 2020 Dec 18.